GlobeImmune's Convertible Note Round

GlobeImmune raised a round of funding on February 13, 2014.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Convertible Note Round: